HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of albendazole efficiency and complications in patients with pulmonary hydatid cyst.

AbstractOBJECTIVES:
This study investigated the efficacy and complications of albendazole use after surgery in patients with pulmonary hydatid cysts.
METHODS:
One hundred fifty-three consecutive patients who met the study criteria out of 215 patients who received prophylaxis with albendazole after surgery for isolated pulmonary hydatid cysts in our clinic between January 2011 and December 2020 were analysed retrospectively.
RESULTS:
Eighty-six out of 153 (56.2%) of cases were male and 67 (43.8%) were female. The average age was 24.6 ± 17.4 (between 3 and 71 years), 76 of them (49.7%) were 18 years old and younger, while 77 (50.3%) were adults. All cases were approached transthoracically and a total of 170 operations were performed on the 153 cases. Fever, weakness and dizziness were reported in only one patient who was given albendazole treatment. A partial increase in liver enzymes was observed in 16 cases (10.5%) after albendazole treatment. Mild leukopoenia and neutropenia were observed in only one of the cases. In 1 case, a second operation was performed 30 months later due to recurrence. Albendazole treatment was not required to be discontinued in any of the cases. Mortality was not observed in any of the cases. Factors such as mean age, cyst size and hospitalization period did not have a statistically significant effect on any changes in liver enzymes tests following albendazole therapy (P > 0.05).
CONCLUSIONS:
Albendazole treatment can safely be used for postoperative prophylaxis in patients with pulmonary hydatid cysts in a controlled manner without causing serious complications.
SUBJ COLLECTION:
152.
AuthorsYener Aydin, Ali Bilal Ulas, Ilker Ince, Asli Kalin, Fatma Kesmez Can, Betul Gundogdu, Kamber Kasali, Bugra Kerget, Yasemin Ogul, Atilla Eroglu
JournalInteractive cardiovascular and thoracic surgery (Interact Cardiovasc Thorac Surg) Vol. 34 Issue 2 Pg. 245-249 (01 18 2022) ISSN: 1569-9285 [Electronic] England
PMID34587626 (Publication Type: Journal Article)
Copyright© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
Chemical References
  • Albendazole
Topics
  • Adolescent
  • Adult
  • Aged
  • Albendazole (adverse effects)
  • Child
  • Child, Preschool
  • Echinococcosis, Hepatic (complications, drug therapy, surgery)
  • Echinococcosis, Pulmonary (complications, surgery)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: